An interventional study of incentive spirometer and walking with dog and training by incentive spirometer only in End Stage Renal Disease and Hemolysis, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-03-06.
Sponsored by Cairo University · Not applicable, Interventional, and Prevention
adolescents with chronic renal failure going on hemodialysis usually complain many problems including compromised ventilation, early fatigue, early physical intolerance, and bad life quality. incentive spirometer is highly recommended to improve these problems. also, walking program, especially walking with dog, can increase the benefits of incentive spirometer
End stage renal diseased adolescents (numbering forty) will be grouped randomly to two random groups, twenty adolescents in group I or group II. Both groups will trained by incentive spirometer 30 min during the sessions of dialysis three applications weekly for 12 weeks. Group I will additionally walked freely with a dog 30 min three times weekly (in opposite days of hemodialysis). The duration of this trial will be 12 weeks.
2,108 studies on the registry are indexed under Kidney Failure, Chronic; 273 are open to participants now.
This study's planned enrollment of 40 is below the median of 57 across 1,569 interventional studies indexed under Kidney Failure, Chronic.
Browse Kidney Failure, Chronic studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
End stage renal diseased adolescents (numbering twenty) will trained by incentive spirometer 30 min during the sessions of dialysis three applications weekly for 12 weeks. they will additionally walked freely with a dog 30 min three times weekly (in opposite days of hemodialysis). The duration of this trial will be 12 weeks.
Other: incentive spirometer and walking with dog
End stage renal diseased adolescents (numbering twenty) will trained by incentive spirometer 30 min during the sessions of dialysis three applications weekly for 12 weeks.
Other: training by incentive spirometer only
End stage renal diseased adolescents (numbering twenty) will trained by incentive spirometer 30 min during the sessions of dialysis three applications weekly for 12 weeks. they will additionally walked freely with a dog 30 min three times weekly (in opposite days of hemodialysis). The duration of this trial will be 12 weeks.
End stage renal diseased adolescents (numbering twenty) will trained by incentive spirometer 30 min during the sessions of dialysis three applications weekly for 12 weeks.
six minute walk testing
it is a physical capacity measure
Time frame: it will be measured after 12 weeks
forced vital capacity
it is a pulmonary function test
Time frame: it will be measured after 12 weeks
forced expiratory volume at first second
it is a pulmonary function test
Time frame: it will be measured after 12 weeks
maximal inspiratory pressure
it is a test measures strength of inspiratory muscles
Time frame: it will be measured after 12 weeks
child health questionnaire (physical summary)
the parent form (50 questions) will used to measure quality of life
Time frame: it will be measured after 12 weeks
child health questionnaire (mental summary)
the parent form (50 questions) will used to measure quality of life
Time frame: it will be measured after 12 weeks
fatigue symptoms inventory
it is a questionnaire assesses fatigue
Time frame: it will be measured after 12 weeks
Started Feb 2025 (actual). Primary completion is estimated for Jun 2025, 3 months after the start.
Of 347 non-industry interventional studies with no phase under Kidney Failure, Chronic, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 47. This study's planned 3 months is below that.
Counting every sponsor, half of 425 studies reached it within 23 months; a quarter within 8 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.